Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
Clinical trial NCT02586337 · UNKNOWN
Trial details
- NCT number
- NCT02586337
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2019-12-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.